Substance / Medication

Isoproterenol

Overview

Active Ingredient
isoproterenol
RxNorm CUI
6054

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

12 trials linked to this intervention

12
Total Trials
1
Recruiting
4
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Oral caffeine intake amplifies the effect of isoproterenol in patients with frequent premature ventricular contractions.
Hasebe Hideyuki, Yoshida Kentaro, Furuyashiki Yoshitaka et al. · Europace · 2020
PMID: 32500131RCT
Clinical value of noninducibility by high-dose isoproterenol versus rapid atrial pacing after catheter ablation of paroxysmal atrial fibrillation.
Crawford Thomas, Chugh Aman, Good Eric et al. · J Cardiovasc Electrophysiol · 2010
PMID: 19682170RCT
Bolus isoproterenol infusions provide a reliable method for assessing interoceptive awareness.
Khalsa S S, Rudrauf D, Sandesara C et al. · Int J Psychophysiol · 2009
PMID: 18854201RCTFull text (PMC)
Inducibility of paroxysmal atrial fibrillation by isoproterenol and its relation to the mode of onset of atrial fibrillation.
Oral Hakan, Crawford Thomas, Frederick Melissa et al. · J Cardiovasc Electrophysiol · 2008
PMID: 18266669RCT
A mechanistic study to assess whether isoproterenol can reverse the negative chronotropic effect of fingolimod.
Kovarik John M, Riviere Gilles-Jacques, Neddermann Daniel et al. · J Clin Pharmacol · 2008
PMID: 18218783RCT
Consecutive administration of atropine and isoproterenol for the evaluation of asymptomatic sinus bradycardia.
Vavetsi Spiridoula, Nikolaou Nikolaos, Tsarouhas Konstantinos et al. · Europace · 2008
PMID: 18701603RCT
Endoluminal isoproterenol irrigation decreases renal pelvic pressure during flexible ureterorenoscopy: a clinical randomized, controlled study.
Jung Helene, Nørby Bettina, Frimodt-Møller Poul Chr et al. · Eur Urol · 2008
PMID: 18403102RCT
Comparative analysis of isoproterenol- and lipopolysaccharide-mediated cytoprotective responses in the heart.
Lim Kenji Rowel Q, Amrute Junedh, Diwan Abhinav et al. · Am J Physiol Heart Circ Physiol · 2025
PMID: 41101778ObservationalFull text (PMC)
The role of HS in isoproterenol-induced cardiac hypertrophy: A comparative study using slow releaser GYY4137 and a newly synthetized fast releaser BM-112.
Gyöngyösi Alexandra, Eskeif Simon, Kajtár Richard et al. · Biomed Pharmacother · 2025
PMID: 41124863Observational

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Isoprenaline (substance)
SNOMED CT
372781009
UMLS CUI
C0022245
RxNorm CUI
6054

Clinical Data

This intervention maps to 7 entities in the Healos knowledge graph.

7
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
12
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.